A polydopamine nanospheres modified fiber optic SPR biosensor for specific detection of C-reactive protein

被引:12
|
作者
Cao, Guangxiao [1 ,2 ]
Chang, Pengxiang [1 ,2 ,3 ]
Zhang, Ailing [1 ,2 ]
Liu, Fei [1 ,2 ]
Pan, Honggang [1 ,2 ]
Wang, Junfeng [1 ,2 ]
Lin, Sihang [1 ,2 ]
Yang, Tengfei [1 ,2 ]
机构
[1] Tianjin Univ Technol, Tianjin 300384, Peoples R China
[2] Tianjin Key Lab Thin Film Elect & Commun Devices, Tianjin 300384, Peoples R China
[3] Natl Key Lab Electromagnet Space Secur, Tianjin 300308, Peoples R China
关键词
C-reactive protein; Polydopamine nanospheres; Surface plasmon resonance; Optical biosensor; Immune reaction; PLASMON RESONANCE BIOSENSOR; GOLD;
D O I
10.1016/j.yofte.2023.103468
中图分类号
TM [电工技术]; TN [电子技术、通信技术];
学科分类号
0808 ; 0809 ;
摘要
C-reactive protein (CRP) is a vital inflammatory marker in humans and a key single marker of cardiovascular diseases. In this paper, the concentration of CRP was specifically detected by a polydopamine nanospheres (PDANPs) developed surface plasmon resonance (SPR) sensor with high accuracy. PDA-NPs is a self-polymerizing material that can be obtained from dopamine through the mussel adhesion effect. The PDA-NPs (diameter & AP; 100 nm) modified SPR sensor exhibits enhanced refractive index (RI) sensitivity and bio-sensitivity attributed to the large specific surface area and high surface reactivity of the PDA-NPs. The developed sensor demonstrates a RI sensitivity of 2427.68 nm/RIU, presenting a 55.7% increase compared to the raw sensor (RI sensitivity was 1559.08 nm/RIU). Moreover, the developed biosensor is used to detect CRP specifically. The bio-sensitivity reaches 0.09 nm/(& mu;g/mL), while the limit of detection (LOD) reaches 0.22 & mu;g/mL. These findings indicate that the developed biosensor can specifically detect CRP with a low LOD. Therefore, this PDA-NPs modified biosensor has great potential in clinical detection and other bio-detection filed.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Reusability study of fiber optic based protein C biosensor
    Spiker, JO
    Drohan, WN
    Kang, KA
    OXYGEN TRANSPORT TO TISSUE XXI, 1999, 471 : 731 - 739
  • [42] DETECTION OF C-REACTIVE PROTEIN IN CASES OF LEPROSY
    KABAKOV, EN
    JOURNAL OF MICROBIOLOGY EPIDEMIOLOGY AND IMMUNOBIOLOGY USSR, 1961, 32 (03): : 448 - +
  • [43] Enhanced Sensitivity Mach-Zehnder Interferometer-Based Tapered-in-Tapered Fiber-Optic Biosensor for the Immunoassay of C-Reactive Protein
    Xiao, Lei
    Chen, Xinghong
    Li, Xuejin
    Zhang, Jinghan
    Wang, Yan
    Li, Dongqing
    Hong, Xueming
    Shao, Yonghong
    Chen, Yuzhi
    BIOSENSORS-BASEL, 2025, 15 (02):
  • [44] DIETARY FIBER, SODIUM, HYPERTENSION AND C-REACTIVE PROTEIN
    DODSON, PM
    SHINE, B
    GALTON, DJ
    LANDON, J
    PROCEEDINGS OF THE NUTRITION SOCIETY, 1982, 41 (02) : A51 - A51
  • [45] Fiber and C-reactive protein in diabetes, hypertension, and obesity
    King, DE
    Mainous, AG
    Egan, BM
    Woolson, RF
    Geesey, ME
    DIABETES CARE, 2005, 28 (06) : 1487 - 1489
  • [46] Application of spectral SPR imaging for the surface analysis of C-reactive protein binding
    Yuk, Jong Seol
    Hong, Duk-Geun
    Jung, Hyo-Il
    Ha, Kwon-Soo
    SENSORS AND ACTUATORS B-CHEMICAL, 2006, 119 (02) : 673 - 675
  • [47] Modified C-Reactive Protein Selectively Binds to Immunoglobulins
    Boncler, M.
    Dudzinska, D.
    Nowak, J.
    Watala, C.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2012, 76 (01) : 1 - 10
  • [48] Oriented immobilization of c-reactive protein on solid surface for biosensor applications
    Zhavnerko, GK
    Yi, SJ
    Chung, SH
    Yuk, JS
    Ha, KS
    FRONTIERS OF MULTIFUNCTIONAL INTEGRATED NANOSYSTEMS, 2004, 152 : 95 - 108
  • [49] Effect of modified C-reactive protein on complement activation - A possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions
    Ji, SR
    Wu, Y
    Potempa, LA
    Liang, YH
    Zhao, J
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (04) : 935 - 941
  • [50] Is C-Reactive Protein a Specific Marker in Melanoma? Reply
    Fang, Shenying
    Wang, Yuling
    Amos, Christopher I.
    Lee, Jeffrey E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (31) : 3674 - +